bioMerieux
Rating Overview
Rating Criteria
Rating Criteria Detail
Corporate Weaponization
Criteria:
Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Risk Level:
MediumRationale:
bioMerieux integrates ESG into its business practices. From its Sustainable Procurement and Supplier Relations Charter: Suppliers must report on “the environment, for instance by taking into account issues associated with changes in fossil fuels, emissions pricing, energy consumption, raw materials, carbon footprints, waste management and lifecycle management” (1). The company ‘Global Supplier Code of Conduct’ requires international vendors to include sexual orientation in their nondiscrimination policy, promoting divisive sex and gender policies (2). However, the company has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (3).
Criteria:
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Risk Level:
LowerCriteria:
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Risk Level:
HighRationale:
bioMerieux appears to prioritize diversity over merit in its leadership composition. From its 2024 Universal Registration Document: “Accordingly, the Board of Directors has established a policy of promoting cultural and international diversity among its members;… aiming for gender equality” (1). The company does not provide viewpoint protections for its employees (2).
Corporate Governance and Public Policy
Criteria:
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Risk Level:
HighRationale:
bioMerieux has “[integrated] the Company’s CSR ambitions into [its] corporate strategy” and claims Corporate Social Responsibility is its “DNA” (1). The company supports ESG within its business practices. From its 2024 Universal Registration Document: “This report is based on a double materiality approach, which takes into account both bioMérieux’s impact on the environment and society and the impact of environmental, social and governance (ESG) topics on the Company’s performance” (2).
Criteria:
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Risk Level:
LowerRationale:
bioMerieux has not used corporate funds to advance ideological causes, organizations, or policies (1).